Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.11. | City View Green Holdings Inc: City View Green issues 78.08 million shares for debt | 1 | Stockwatch | ||
27.11. | City View Green Holdings Inc. Completes Issuance of Shares in Settlement of Debt | 159 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 27, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
06.11. | City View Green Holdings Inc. Announces Completion of Strategic Review and Debt Settlements | 254 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 6, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
18.10. | Canadian Cannabis Edibles Producer City View Green To Raise $730K Via Private Placement | 2 | Benzinga.com | ||
17.10. | City View Green Holdings Inc: City View Green arranges $1-million private placement | 1 | Stockwatch | ||
17.10. | City View Green Holdings Inc.: City View Announces Private Placement of up to $1,000,000 and Enters into IR Agreement | 180 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 17, 2024) - City View Green Holdings Inc. (CSE: CVGR) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles manufacturing... ► Artikel lesen | |
21.06. | City View Green Holdings Inc.: City View Green Announces First Tranche Closing and Extension of its Non-Brokered Private Placement | 563 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 20, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
06.05. | City View Green Holdings Inc.: City View Extends Private Placement of up to $1,000,000 | 525 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 6, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
CITY VIEW GREEN Aktie jetzt für 0€ handeln | |||||
17.04. | City View Green Holdings Inc. Exits Retail Cannabis Through Ownership in Budd Hutt & Announces Director Resignation | 485 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
04.03. | City View Green Holdings Inc.: City View Announces Private Placement of Up To $1,000,000 | 593 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 4, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 18,936 | +0,35 % | DAX stabil, Bitcoin mit neuem Rekord: Vertrauensfrage, VW, Rheinmetall, Munich Re, Bayer im ... | Am Freitag hat der DAX bis auf ein neues Rekordhoch bei 20.522,82 Zählern steigen können, bevor ihm zunächst die Luft ausging. Am Ende verabschiedete er sich 0,1 Prozent tiefer als am Donnerstag bei... ► Artikel lesen | |
PFIZER | 25,300 | +0,06 % | JPMORGAN stuft PFIZER INC auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem Kursziel von 30 US-Dollar auf "Neutral" belassen. Die Umsatz- und Ergebnisziele für 2025 seien weitgehend wie... ► Artikel lesen | |
SANOFI | 91,28 | +0,10 % | DEUTSCHE BANK RESEARCH stuft SANOFI auf 'Sell' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Sanofi mit einem Kursziel von 85 Euro auf "Sell" belassen. Dies schrieb der Analyst Emmanuel Papadakis in seiner am Dienstag... ► Artikel lesen | |
INNOCAN PHARMA | 0,121 | 0,00 % | Innocan Pharma Corporation: Innocan Pharma Announces Private Placement of Units | HERZLIYA, Israel and CALGARY, AB, Dec. 19, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it... ► Artikel lesen | |
DERMAPHARM | 38,000 | 0,00 % | Leichter Wertverlust bei der Dermapharm-Aktie (37,05 €) | Im Minus liegt zur Stunde die Aktie von Dermapharm . Der jüngste Kurs betrug 37,05 Euro. Heute hat sich am deutschen Aktienmarkt die Dermapharm-Aktie zwischenzeitlich um 1,20 Prozent verbilligt. Der... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
BAUSCH HEALTH | 7,140 | -0,13 % | Bausch Health Companies Inc.: Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb | LAVAL, QC / ACCESSWIRE / December 12, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives through... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,003 | 0,00 % | CSE Bulletin: Reinstatement - WPD Pharmaceuticals Inc. (WBIO) | Toronto, Ontario--(Newsfile Corp. - le 20 décembre/December 2024) - Effective immediately, WPD Pharmaceuticals Inc. will be reinstated for trading. The Company has rectified the situation... ► Artikel lesen | |
SINOPHARM | 2,638 | +0,73 % | Lakeside enters into $1.5M sales deal with Sinopharm Hubei | ||
INDIVA | 0,016 | 0,00 % | SNDL Inc.: SNDL Emerges as Canada's Leading Producer of Edibles with Indiva Acquisition | CALGARY, AB, Nov. 4, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that, in the context of Indiva Limited's ("Indiva" and together... ► Artikel lesen | |
CSPC PHARMA | 0,600 | 0,00 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - SYS6005 (ANTIBODY-DRUG CONJUGATE) OBTAINS CLINICAL TRIAL APPROVAL | ||
ORAMED PHARMACEUTICALS | 2,330 | +2,28 % | ORAMED PHARMACEUTICALS INC. - 8-K, Current Report | ||
ADASTRA | 0,149 | -42,25 % | Adastra Holdings Ltd.: Adastra Holdings Announces Annual General Meeting | Langley, British Columbia--(Newsfile Corp. - December 10, 2024) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) ("Adastra" or the "Company"), a leader in cannabis processing and production, is pleased... ► Artikel lesen | |
CATALYST PHARMACEUTICALS | 20,330 | -0,29 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE in Japan | CORAL GABLES, Fla., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule amends, settles, converts debentures |